(Q42979548)

12 November 2017

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin (English)

1 reference

12 November 2017

1 reference

1 reference

6

Ran Taube

1 reference

12 November 2017

Avis Dafa-Berger

1

1 reference

12 November 2017

Alona Kuzmina

2

1 reference

12 November 2017

Michael Fassler

3

1 reference

12 November 2017

Hila Yitzhak-Asraf

4

1 reference

12 November 2017

Yonat Shemer-Avni

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

20 April 2012

1 reference

12 November 2017

1 reference

12 November 2017

428

1 reference

12 November 2017

2

1 reference

12 November 2017

98-111

1 reference

Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Targeting lipid metabolism in the treatment of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

From structure to function: new insights into hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Novel insights into hepatitis C virus replication and persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Assembly of infectious hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Molecular determinants and dynamics of hepatitis C virus secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Trafficking of hepatitis C virus core protein during virus particle assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

The great escape: viral strategies to counter BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Evasion of intracellular host defence by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

The interferon response circuit: induction and suppression by pathogenic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Emerging host cell targets for hepatitis C therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Intracellular innate immune cascades and interferon defenses that control hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Hepatitis C virus: assembly and release of virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Molecular biology of flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Unravelling hepatitis C virus replication from genome to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Host factors involved in retroviral budding and release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

The lipid droplet is an important organelle for hepatitis C virus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Turning hepatitis C into a real virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Towards a small animal model for hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Cellular cofactors affecting hepatitis C virus infection and replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

BST-2 mediated restriction of simian-human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

RIG-I mediated hepatic innate immune signaling that controls HCV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Interferon signaling and treatment outcome in chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

A diverse range of gene products are effectors of the type I interferon antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Mechanisms of HCV survival in the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Epidemiology of hepatitis C: geographic differences and temporal trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Global challenges in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.011

10.1016/J.VIROL.2012.03.011

7 January 2021

Identifiers

DOI

1 reference

release_m5i37blvejdnjfpzmf3npankpm

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m5i37blvejdnjfpzmf3npankpm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference